Details for Patent: 11,679,210
✉ Email this page to a colleague
Which drugs does patent 11,679,210 protect, and when does it expire?
Patent 11,679,210 protects RYALTRIS and is included in one NDA.
This patent has eighty-eight patent family members in thirty-two countries.
Drugs Protected by US Patent 11,679,210
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Speclt | RYALTRIS | mometasone furoate; olopatadine hydrochloride | SPRAY, METERED;NASAL | 211746-001 | Jan 13, 2022 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,679,210
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3043773 | ⤷ Subscribe | CA 2021 00050 | Denmark | ⤷ Subscribe |
| European Patent Office | 3043773 | ⤷ Subscribe | 301154 | Netherlands | ⤷ Subscribe |
| European Patent Office | 3043773 | ⤷ Subscribe | 122021000085 | Germany | ⤷ Subscribe |
| European Patent Office | 3043773 | ⤷ Subscribe | 132021000000191 | Italy | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
